Nuvation Bio NUVB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $143.05M+1,206% | $62.9M+699% | $26.75M+1,137% | $14.36M+900% | $10.96M— | ||
| $125.55M+13.2% | $115.11M+16.1% | $110.11M+29.3% | $108.99M+43.4% | $110.88M+69.7% | ||
| $154.48M+58.8% | $151.56M+119% | $137.37M+183% | $119.6M+225% | $97.27M+245% | ||
| $714K-21.9% | $722K-26.0% | $783K-22.4% | $849K-15.1% | $914K-7.1% | ||
| $295.32M-54.0% | $278.06M-53.7% | $256.65M-54.1% | $237.76M-55.8% | $642.39M+587% | ||
| $295.32M-54.0% | $278.06M-53.7% | $256.65M-54.1% | $237.76M-55.8% | $642.39M+587% | ||
| $20.34M+5,048% | $13.68M+3,912% | $7.1M+2,717% | $684K+418% | $395K— | ||
| —— | —— | $15.49M-43.1% | $21.74M-19.6% | $25.05M+1.7% | ||
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| -102.1%+5,432pp | -325.3%+6,888pp | -813.1%+23,807pp | -1,413.4%+34,177pp | -5,534.2%— | ||
| -$0.42+80.9% | -$0.60+71.6% | -$0.49+77.5% | -$0.48+77.4% | -$2.20-588% | ||
| 1.4B+24.6% | 1.4B+35.5% | 1.3B+35.0% | 1.2B+35.5% | 1.1B+28.5% | ||
| 1.4B+21.9% | 1.4B+35.5% | 1.3B+35.0% | 1.2B+35.5% | 1.1B+28.5% | ||
| —— | —— | —— | —— | $7.4M— | ||
| -$148.22M+75.5% | -$205.39M+63.8% | -$219M+58.5% | -$201.96M+60.2% | -$604.67M-801% | ||
| $12K-98.3% | $741K+611% | -$2.16M-122% | $732K-86.0% | $712K-82.3% | ||
| —— | —— | —— | —— | -$3.61M— | ||
| $7.72M— | $4.42M— | —— | —— | —— | ||
| $202.03M— | $202.54M— | —— | —— | —— | ||
| —— | —— | —— | $189.95M+190% | $169.34M+147% | ||
| -$125.73M+20.1% | -$173.43M-33.0% | -$190M-91.6% | -$168.19M-99.7% | -$157.34M-144% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.25M+2,165% | $1.66M— | $1.07M— | $481K— | ||
| $143.05M+1,206% | $62.9M+699% | $26.75M+1,137% | $14.36M+900% | $10.96M— | ||
| —— | —— | —— | —— | $0— | ||
| $2.23M+323% | $1.5M+379% | -$637K-207% | -$208K-40.5% | -$1M— | ||
| -$148.21M+76.5% | -$211.33M+64.3% | -$231.55M+58.6% | -$223.59M+58.4% | -$630.5M-576% | ||
| -103.6%+5,651pp | -336%+7,183pp | -865.7%+24,990pp | -1,557.6%+35,888pp | -5,754.3%— | ||
| -$150.18M+76.2% | -$213.06M+64.0% | -$232.97M+58.4% | -$224.64M+58.2% | -$631.43M-575% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.